The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Lessons learned from the contamination of heparin
Open accessAbstract
Heparin is unique as one of the oldest drugs currently still in widespread clinical use as an anticoagulant, a natural product, one of the first biopolymeric drugs, and one of the few carbohydrate drugs. Recently, certain batches of heparin have been associated with anaphylactoid-type reactions, some leading to hypotension and death. These reactions were traced to contamination with a semi-synthetic oversulfated chondroitin sulfate (OSCS). This Highlight reviews the heparin contamination crisis, its resolution, and the lessons learned. Pharmaceutical scientists now must consider dozens of natural and synthetic heparinoids as potential heparin contaminants. Effective assays, which can detect both known and unknown contaminants, are required to monitor the quality of heparin. Safer and better-regulated processes are needed for heparin production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Order Out of Chaos: Assembly of Ligand Binding Sites in Heparan Sulfate
Esko, J. D., & Selleck, S. B. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135458 · Cited by 1,495
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events
Guerrini, M., Beccati, D., Shriver, Z., Naggi, A., Viswanathan, K., Bisio, A., Capila, I., Lansing, J. C., Guglieri, S., Fraser, B., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1407 · Cited by 628
Self-citationRoles of heparan-sulphate glycosaminoglycans in cancer
Sasisekharan, R., Shriver, Z., Venkataraman, G., & Narayanasami, U. (2002) · Nature Reviews Cancer · doi:10.1038/nrc842 · Cited by 621
Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System
Kishimoto, T. K., Viswanathan, K., Ganguly, T., Elankumaran, S., Smith, S., Pelzer, K., Lansing, J. C., Sriranganathan, N., Zhao, G., Galcheva-Gargova, Z., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0803200 · Cited by 621
CELL-SURFACE GLYCOSAMINOGLYCANS
Höök, M., Kjellén, L., Johansson, S., & Robinson, J. (1984) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.53.070184.004215 · Cited by 566
Cell-Surface Glycosaminoglycans
Hook, M. (1984) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.53.1.847 · Cited by 550
Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.
Lindahl, U., Bäckström, G., Thunberg, L., & Leder, I. G. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6551 · Cited by 498
2003 Claude S. Hudson Award Address in Carbohydrate Chemistry. Heparin: Structure and Activity
Linhardt, R. J. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030176m · Cited by 493
Self-citationStructural Insights into Biological Roles of Protein-Glycosaminoglycan Interactions
Raman, R., Sasisekharan, V., & Sasisekharan, R. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.11.020 · Cited by 434
Structure and Biological Activity of Heparin
Casu, B. (1985) · Advances in Carbohydrate Chemistry and Biochemistry · doi:10.1016/s0065-2318(08)60067-0 · Cited by 428
Pharmacokinetic and Pharmacodynamic Properties of Oral Anticoagulants, Especially Phenprocoumon
Haustein, K.-O. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-996417 · Cited by 387
Idraparinux versus Standard Therapy for Venous Thromboembolic Disease
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa064247 · Cited by 335
Control of Angiogenesis with Synthetic Heparin Substitutes
Folkman, J., Weisz, P. B., Joullié, M. M., Li, W. W., & Ewing, W. R. (1989) · Science · doi:10.1126/science.2467380 · Cited by 289
Contribution of monosaccharide residues in heparin binding to antithrombin III
Atha, D. H., Lormeau, J. C., Petitou, M., Rosenberg, R. D., & Choay, J. (1985) · Biochemistry · doi:10.1021/bi00344a063 · Cited by 255
Heparin-Binding Domains in Vascular Biology
Muñoz, E. M., & Linhardt, R. J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000137189.22999.3f · Cited by 212
Self-citationA proteoglycan form of heparin and its degradation to single-chain molecules.
Robinson, H. C., Horner, A. A., Höök, M., Ogren, S., & Lindahl, U. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37973-5 · Cited by 211
Preparation and structural characterization of large heparin-derived oligosaccharides
Pervin, A., Gallo, C., Jandik, K. A., Han, X.-J., & Linhardt, R. J. (1995) · Glycobiology · doi:10.1093/glycob/5.1.83 · Cited by 202
Self-citationSolution Structures of Chemoenzymatically Synthesized Heparin and Its Precursors
Zhang, Z., McCallum, S. A., Xie, J., Nieto, L., Corzana, F., Jiménez-Barbero, J., Chen, M., Liu, J., & Linhardt, R. J. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8026345 · Cited by 168
Self-citationConformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation
Maruyama, T., Toida, T., Imanari, T., Yu, G., & Linhardt, R. J. (1998) · Carbohydrate Research · doi:10.1016/s0008-6215(97)10060-x · Cited by 158
Self-citationTherapeutic uses of heparin beyond its traditional role as an anticoagulant
Tyrrell, D. J., Kilfeather, S., & Page, C. P. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89022-7 · Cited by 155
Petitou, M., Duchaussoy, P., Lederman, I., Choay, J., Sînaÿ, P., Jacquinet, J., & Torri, G. (1986) · Carbohydrate Research · doi:10.1016/s0008-6215(00)90633-5 · Cited by 152
Marino, M., Banerjee, M., Jonquières, R., Cossart, P., & Ghosh, P. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf558 · Cited by 132
Heparin inhibits dengue-2 virus infection of five human liver cell lines
Lin, Y.-L., Lei, H., Lin, Y., et al. (2002) · Antiviral Research · doi:10.1016/s0166-3542(02)00095-5 · Cited by 131
Loganathan, D., Wang, H. M., Mallis, L. M., & Linhardt, R. J. (1990) · Biochemistry · doi:10.1021/bi00470a015 · Cited by 130
Self-citationGeneration of “Neoheparin” from E. coli K5 Capsular Polysaccharide
Lindahl, U., Li, J., Kusche‐Gullberg, M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049812m · Cited by 117
Using an Enzymatic Combinatorial Approach to Identify Anticoagulant Heparan Sulfate Structures
Chen, J., Jones, C. L., & Liu, J. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.07.015 · Cited by 109
Glycosaminoglycans: Structure and Interactio
Chakrabarti, B., Park, J. W., & Stevens, E. S. (1980) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238009102572 · Cited by 102
Sudhalter, J., Folkman, J., Svahn, C. M., Bergendal, K., & D'Amore, P. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83515-3 · Cited by 77
Zhang, Z., Weïwer, M., Li, B., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800785t · Cited by 64
Self-citationMuñoz, E. M., Xu, D., Avci, F. Y., Kemp, M. M., Liu, J., & Linhardt, R. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.051 · Cited by 47
Self-citationEnzymatic Synthesis of Glycosaminoglycan Heparin
Linhardt, R. J., Dordick, J. S., DeAngelis, P. L., & Liu, J. (2007) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-982076 · Cited by 47
Self-citationEdens, R. E., Fromm, J. R., Fromm, S. J., Linhardt, R. J., & Weiler, J. M. (1995) · Biochemistry · doi:10.1021/bi00008a002 · Cited by 18
Self-citationSequeira, S. J., & McKenna, T. J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-3-780 · Cited by 17
Capila, I., & Linhardt, R. J. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020201)41:3<390::aid-anie390>3.0.co;2-b
Self-citation
Cited by
Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research
Boltje, T. J., Buskas, T., & Boons, G.-J. (2009) · Nature Chemistry · doi:10.1038/nchem.399 · Cited by 740
Chemically Modified Biopolymers for the Formation of Biomedical Hydrogels
Muir, V. G., & Burdick, J. A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00923 · Cited by 604
Assessment of Recent Process Analytical Technology (PAT) Trends: A Multiauthor Review
Simon, L. L., Pataki, H., Marosi, G., Meemken, F., Hungerbühler, K., Baiker, A., Tummala, S., Glennon, B., Kuentz, M., Steele, G., et al. (2015) · Organic Process Research & Development · doi:10.1021/op500261y · Cited by 439
Chemoenzymatic Synthesis of Homogeneous Ultralow Molecular Weight Heparins
Xu, Y., Masuko, S., Takieddin, M., Xu, H., Liu, R., Jing, J., Mousa, S. A., Linhardt, R. J., & Liu, J. (2011) · Science · doi:10.1126/science.1207478 · Cited by 407
Self-citationGreen Solvents in Carbohydrate Chemistry: From Raw Materials to Fine Chemicals
Farrán, A., Cai, C., Sandoval, M., Xu, Y., Liu, J., Hernáiz, M. J., & Linhardt, R. J. (2015) · Chemical Reviews · doi:10.1021/cr500719h · Cited by 393
Self-citation
Metadata
- Authors
- Liu, H., Zhang, Z., & Linhardt, R. J.
- Venue
- Natural Product Reports
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2009
- Volume
- 26
- Issue
- 3
- Pages
- 313
- ISSN
- 0265-0568 (ISSN-L)
- 1460-4752
- OpenAlex
- W2151178558
- Cited by
- 396
- References
- 34
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.